Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety and Tolerability of Intranasal Insulin in Parkinson’s Disease

Author:Johnson, Julia   Kashyap, Bhavani   Gustafson, Sally   Wyman-Chick, Kathryn   O'Brien, Meghan   Frey, William   Svitak, Aleta   Hanson, Leah   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.018  

Author Institution:HealthPartners Neuroscience Center, St Paul, MN  HealthPartners Neuroscience Center, Saint Paul, MN  HealthPartners Institute, Bloomington, MN  HealthPartners Neuroscience Center/Neuropsychology, Saint Paul, MN  HealthPartners Neuroscience Center, St. Paul, MN  

Motivations and Burdens of Participation in Parkinson’s Disease Clinical Trials: Experiences from a Disease-modifying Phase 2 Study

Author:Tharp, Emily   Martinez Lemus, Juan   Thyne, Vanessa   Onuigbo, Chiamaka   Le, Tran   Ritter III, Robert   Schiess, Mya   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.019  

Author Institution:McGovern Medical School at UTHealth Houston, Houston, TX  

Opicapone Improved Parkinson’s Disease-related Sleep Disturbances: Findings from the OASIS Study

Author:Gago, Miguel   Costa, Raquel   Fonseca, Miguel   Almeida, Joana   Brigas, Helena   Banisadr, Ghazal   Rocha, José-Francisco   Holenz, Joerg   Ferreira, Joaquim   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.020  

Author Institution:Department of Neurology, ULS Alto Ave, Hospital da Senhora da Oliveira  Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho  CNS - Campus Neurológico, Guimarães, Portugal  BIAL – Portela & Ca S.A., CORONADO (S. Romão E S. Mamede, Portugal  Amneal Pharmaceuticals, Evanston, IL  IMM Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa  CNS-Campus Neurológico, Instituto De Medicin, Portugal  

Attitudes and Beliefs in Parkinson’s Disease (PD) Research Participation

Author:Nanda Kumar, Prisha   Meng, Cheryl   Korell, Monica   Valdeverde Twiggs, Julien   Brown, Ethan   Comyns, Kathleen   Xuejie Chen, Sue   Clark, Adrienne   Tanner, Caroline   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.021  

Author Institution:Philadelphia College of Osteopathic Medicine, Suwanee, GA  University of California San Francisco, Chicago, IL  University of California, San Francisco, San Francisco, CA  UCSF, San Francisco, CA  University of California San Francisco, Weill Institute for Neurosciences, SAN FRANCISCO, CA  

A Noninterventional Study to Evaluate Real-world Feasibility, Compliance, and Satisfaction with Digital Health Technologies for Parkinson’s Disease

Author:Abid, Nauman   Stemple, Whitney   Komuravelli, Madhu Kumar   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.022  

Author Institution:BlueRock Therapeutics LP, Cambridge, MA  BlueRock Therapeutics LP, San Marcos, CA